IDP PHARMA
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs). They are currently focused on exploiting new mechanisms of action to treat cancer diseases. Multiple myeloma is one of their priorities. IDP Pharma's efforts are directed towards promoting a real shift in cancer therapies to improve the lives of patients. To this end, the company has built an extraordinary committed team of experts in the field, supported by a professional advisory board, including IDPs and diseases experts, and business professionals.
IDP PHARMA
Industry:
Biopharma Biotechnology Medical
Founded:
2015-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.idp-pharma.com
Total Employee:
1+
Status:
Active
Total Funding:
1.67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.idp-pharma.com Semrush global rank: 6.42 M Semrush visits lastest month: 1.03 K
- Host name: 82.223.2.123
- IP address: 82.223.2.123
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "IDP Pharma" on Search Engine
IDP-Pharma
IDP Pharma is a clinical stage company harnessing its proprietary INTRAMETICS™ platform to tackle long-quested disease drivers: intrinsically disordered proteins (IDPs). Our molecules activate the degradation of IDP through the intrinsic cells machinery, representing breakthrough treatments for incurable diseases/cancers. Pipeline.See details»
Pipeline – IDP-Pharma
Our pipeline targets high-value and complex disease drivers, offering a novel approach to selectively degrade therapeutically relevant IDPs. Through internal discovery efforts, we reached clinical stage with our first program (IDP-121).See details»
IDP Pharma - Crunchbase Company Profile & Funding
Company Type For Profit. IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs). They are currently focused on exploiting new mechanisms of action to treat cancer diseases.See details»
IDP Pharma | LinkedIn
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs)....See details»
IDP Pharma announces first patient dosed in a Phase 1/2 Clinical …
Oct 26, 2023 IDP Pharma, a clinical-stage biotechnology company pioneering the development of drugs that directly engage and degrade intrinsically disordered proteins (IDPs), today announced that the first...See details»
IDP Pharma announces first patient dosed in a Phase 1/2 Clinical …
BARCELONA, Spain, Oct. 26, 2023 /PRNewswire/ -- IDP Pharma, a clinical-stage biotechnology company pioneering the development of drugs that directly engage and degrade intrinsically...See details»
First patient dosed in a Phase 1/2 Clinical Trial of IDP-121, a …
First patient dosed in a Phase 1/2 Clinical Trial of IDP-121, a direct cMyc protein inhibitor and degrader. Barcelona, Spain, October 26th 2023 — IDP Pharma, a clinical-stage biotechnology company pioneering the development of drugs that directly engage and degrade intrinsically disordered proteins (IDPs), today announced that the first ...See details»
IDP Pharma | VentureRadar
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs). We are currently focused on exploiting new mechanisms of action to treat cancer diseases.See details»
IDP Pharma - Updates, News, Events, Signals & Triggers
Mar 4, 2024 Organization. IDP Pharma. Connect to CRM. Save. Summary Financials People Technology Signals & News Similar Companies. Growth Insight Details. Powered by AI. IDP Pharma may be growing as it has recently announced the dosing of the first patient in a Phase 1/2 Clinical Trial for its drug IDP-121, which is a direct cMyc protein inhibitor.See details»
IDP Pharma - Funding, Financials, Valuation & Investors
Organization. IDP Pharma. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Funding Rounds 2. Total Funding Amount. Unlock for free. Funding. IDP Pharma has raised a total of. $1.7M. in funding over 2 rounds. Their latest funding was raised on May 18, 2016 from a Seed round. Unlock for free.See details»
IDP Pharma Commences Phase 1/2 Clinical Trial for IDP-121, a …
Friday, October 27, 2023. IDP Pharma, a clinical-stage biotechnology company, is pioneering the development of drugs that directly target and degrade intrinsically disordered proteins (IDPs).See details»
IDP 233 - AdisInsight - Springer
Jun 21, 2021 Request a free trial. IDP 233 is a stapled peptide targeting ASCL1 gene, being developed by IDP Discovery Pharma, for the treatment of neuroendocrine tumours. IDP Pharma utilised.See details»
Idp Pharma | Qualifyze
IDP Pharma is a pharmaceutical research firm that focuses on creating pioneering medications, particularly New Chemical Entities. The organization is committed to pursuing an innovative category of therapeutic targets referred to …See details»
Independent Pharmacy Distributor - Secondary Pharmacy …
1107 W Market Center Dr. High Point, NC 27260 Phone: 1-877-690-0473 Fax: 1-877-690-0473 Email: [email protected]See details»
news Archivos - IDP PHARMA
News. 01 September 2023. The Spanish Agency of Medicines and Medical Devices has authorised the clinical trial of IDP-121, the first drug blocking and degrading a key oncoprotein in several hematological tumors, including multiple myeloma, a currently incurable cancer.See details»
How to create a smart integrated drug development plan including ...
Jun 29, 2021 On this path, an integrated drug development plan (IDP) is an extremely useful tool to increase the overall success rate. This is true for the development of all drugs but is even more important for cell and gene therapies, where conventional development paradigms often don’t apply, and where more tailored approaches are needed.See details»
IDP Pharma - Crunchbase
Companies like IDP Pharma include Healx, NGM Biopharmaceuticals, and Numab. Clementia Pharmaceuticals . Montréal, Quebec, Canada 6 Contacts 5001-10000 employees . Biopharma . Biotechnology . Medical . Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders.See details»
Pharmacy | IDP Education
About Pharmacy. Pharmacy involves preparing and dispensing drugs, providing tailored advice and assisting with long-term patient care. As well as working directly with the public from a retail pharmacy, studying Pharmacy can also help you get into a variety of other roles that contribute to the betterment of society and people’s lives.See details»
Internally Displaced People | UNHCR US
Internally displaced people, referred to as IDPs, have been forced to flee their homes by conflict, violence, persecution or disasters, however, they remain within the borders of their own country. Globally, there are 62.5 million internally displaced people. They account for the majority of the world's forcibly displaced population (58 per cent).See details»
Dengue cases in Americas surpass last year's record high, WHO …
3 days ago Dengue cases have substantially increased in the Americas this year, the World Health Organization (WHO) said on Thursday, which indicates the mosquito-borne viral illness remains a high-risk ...See details»